Visit https://uspatients.pulmonx.com/ for more. The one-time procedure is done during a simple bronchoscopy that require no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced.* Reducing hyperinflation and preventing air from getting trapped in the dis
eased parts of the lung allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath. Some patients treated report immediate relief and the ability to go back to doing everyday tasks with ease.**
The Zephyr® Valves were approved by the FDA in June 2018. Since 2007, more than 25,000 patients have been treated with the Zephyr® Valve worldwide**. The Zephyr® Valve is included in emphysema treatment guidelines issued by leading health organizations worldwide, including the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and the UK’s National Institute for Health and Care Excellence (NICE). Important Safety Information: The Pulmonx Zephyr® Endobronchial Valves are implantable bronchial valves indicated for the bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. Complications of treatment can include but are not limited to pneumothorax (tear in the lung), worsening of COPD symptoms, hemoptysis, pneumonia, and, in rare cases, death. The Zephyr® Valve is contraindicated in patients who have not quit smoking or are allergic to Nitinol (nickel-titanium). Please talk with your physician about other contraindications, warnings, precautions, and adverse events. Only a trained physician can decide whether a particular patient is an appropriate candidate for treatment with the Zephyr® Valve.
*The exact number of valves placed is based on physician discretion and patient anatomy.
**Criner G et al. Am J Respir Crit Care Med. 2018; 198 (9): 1151–1164.
